Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 365 entries
Sorted by: Best Match Show Resources per page
Injectable Hydrogels for Cardiac Tissue Repair after Myocardial Infarction.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Hasan A, Khattab A, Islam MA, Hweij KA, Zeitouny J, Waters R, Sayegh M, Hossain MM, Paul A.
PMID: 27668147
Adv Sci (Weinh). 2015 Jul 15;2(11):1500122. doi: 10.1002/advs.201500122. eCollection 2015 Nov.

Cardiac tissue damage due to myocardial infarction (MI) is one of the leading causes of mortality worldwide. The available treatments of MI include pharmaceutical therapy, medical device implants, and organ transplants, all of which have severe limitations including high...

Cite
Hasan A, Khattab A, Islam MA, et al. Injectable Hydrogels for Cardiac Tissue Repair after Myocardial Infarction. Adv Sci (Weinh). 2015;2(11):1500122doi: 10.1002/advs.201500122.
Hasan, A., Khattab, A., Islam, M. A., Hweij, K. A., Zeitouny, J., Waters, R., Sayegh, M., Hossain, M. M., & Paul, A. (2015). Injectable Hydrogels for Cardiac Tissue Repair after Myocardial Infarction. Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2(11), 1500122. https://doi.org/10.1002/advs.201500122
Hasan, Anwarul, et al. "Injectable Hydrogels for Cardiac Tissue Repair after Myocardial Infarction." Advanced science (Weinheim, Baden-Wurttemberg, Germany) vol. 2,11 (2015): 1500122. doi: https://doi.org/10.1002/advs.201500122
Hasan A, Khattab A, Islam MA, Hweij KA, Zeitouny J, Waters R, Sayegh M, Hossain MM, Paul A. Injectable Hydrogels for Cardiac Tissue Repair after Myocardial Infarction. Adv Sci (Weinh). 2015 Jul 15;2(11):1500122. doi: 10.1002/advs.201500122. eCollection 2015 Nov. PMID: 27668147; PMCID: PMC5033116.
Copy Download .nbib Format: NLM
Systematic review and meta-analysis on the prophylactic role of non-steroidal anti-inflammatory drugs to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis.

World journal of gastrointestinal endoscopy

Sajid MS, Khawaja AH, Sayegh M, Singh KK, Philipose Z.
PMID: 26722616
World J Gastrointest Endosc. 2015 Dec 25;7(19):1341-9. doi: 10.4253/wjge.v7.i19.1341.

AIM: To critically appraise the published randomized, controlled trials on the prophylactic effectiveness of the non-steroidal anti-inflammatory drugs (NSAIDs), in reducing the risk of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis.METHODS: A systematic literature search (MEDLINE, Embase and the Cochrane Library,...

Cite
Sajid MS, Khawaja AH, Sayegh M, et al. Systematic review and meta-analysis on the prophylactic role of non-steroidal anti-inflammatory drugs to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis. World J Gastrointest Endosc. 2015;7(19):1341-9doi: 10.4253/wjge.v7.i19.1341.
Sajid, M. S., Khawaja, A. H., Sayegh, M., Singh, K. K., & Philipose, Z. (2015). Systematic review and meta-analysis on the prophylactic role of non-steroidal anti-inflammatory drugs to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis. World journal of gastrointestinal endoscopy, 7(19), 1341-9. https://doi.org/10.4253/wjge.v7.i19.1341
Sajid, Muhammad S, et al. "Systematic review and meta-analysis on the prophylactic role of non-steroidal anti-inflammatory drugs to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis." World journal of gastrointestinal endoscopy vol. 7,19 (2015): 1341-9. doi: https://doi.org/10.4253/wjge.v7.i19.1341
Sajid MS, Khawaja AH, Sayegh M, Singh KK, Philipose Z. Systematic review and meta-analysis on the prophylactic role of non-steroidal anti-inflammatory drugs to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis. World J Gastrointest Endosc. 2015 Dec 25;7(19):1341-9. doi: 10.4253/wjge.v7.i19.1341. PMID: 26722616; PMCID: PMC4689797.
Copy Download .nbib Format: NLM
Functionalization of graphene using deep eutectic solvents.

Nanoscale research letters

Hayyan M, Abo-Hamad A, AlSaadi MA, Hashim MA.
PMID: 26264683
Nanoscale Res Lett. 2015 Dec;10(1):1004. doi: 10.1186/s11671-015-1004-2. Epub 2015 Aug 12.

Deep eutectic solvents (DESs) have received attention in various applications because of their distinctive properties. In this work, DESs were used as functionalizing agents for graphene due to their potential to introduce new functional groups and cause other surface...

Cite
Hayyan M, Abo-Hamad A, AlSaadi MA, et al. Functionalization of graphene using deep eutectic solvents. Nanoscale Res Lett. 2015;10(1):1004doi: 10.1186/s11671-015-1004-2.
Hayyan, M., Abo-Hamad, A., AlSaadi, M. A., & Hashim, M. A. (2015). Functionalization of graphene using deep eutectic solvents. Nanoscale research letters, 10(1), 1004. https://doi.org/10.1186/s11671-015-1004-2
Hayyan, Maan, et al. "Functionalization of graphene using deep eutectic solvents." Nanoscale research letters vol. 10,1 (2015): 1004. doi: https://doi.org/10.1186/s11671-015-1004-2
Hayyan M, Abo-Hamad A, AlSaadi MA, Hashim MA. Functionalization of graphene using deep eutectic solvents. Nanoscale Res Lett. 2015 Dec;10(1):1004. doi: 10.1186/s11671-015-1004-2. Epub 2015 Aug 12. PMID: 26264683; PMCID: PMC4531886.
Copy Download .nbib Format: NLM
Target Identification of .

Frontiers in pharmacology

Mugumbate G, Mendes V, Blaszczyk M, Sabbah M, Papadatos G, Lelievre J, Ballell L, Barros D, Abell C, Blundell TL, Overington JP.
PMID: 29018348
Front Pharmacol. 2017 Sep 26;8:681. doi: 10.3389/fphar.2017.00681. eCollection 2017.

Mycobacterium phenotypic hits are a good reservoir for new chemotypes for the treatment of tuberculosis. However, the absence of defined molecular targets and modes of action could lead to failure in drug development. Therefore, a combination of ligand-based and...

Cite
Mugumbate G, Mendes V, Blaszczyk M, et al. Target Identification of . Front Pharmacol. 2017;8:681doi: 10.3389/fphar.2017.00681.
Mugumbate, G., Mendes, V., Blaszczyk, M., Sabbah, M., Papadatos, G., Lelievre, J., Ballell, L., Barros, D., Abell, C., Blundell, T. L., & Overington, J. P. (2017). Target Identification of . Frontiers in pharmacology, 8681. https://doi.org/10.3389/fphar.2017.00681
Mugumbate, Grace, et al. "Target Identification of ." Frontiers in pharmacology vol. 8 (2017): 681. doi: https://doi.org/10.3389/fphar.2017.00681
Mugumbate G, Mendes V, Blaszczyk M, Sabbah M, Papadatos G, Lelievre J, Ballell L, Barros D, Abell C, Blundell TL, Overington JP. Target Identification of . Front Pharmacol. 2017 Sep 26;8:681. doi: 10.3389/fphar.2017.00681. eCollection 2017. PMID: 29018348; PMCID: PMC5623190.
Copy Download .nbib Format: NLM
Association analysis of DISC1 gene polymorphisms with Attention-Deficit Hyperactivity Disorder in Iranian population.

Pakistan journal of medical sciences

Kayyal M, Movafagh A, Hashemi M, Sayad A, Emamalizadeh B, PourIran K, Kayyal M, Amirabadi MR, Zamani M, Darvish H.
PMID: 26649006
Pak J Med Sci. 2015 Sep-Oct;31(5):1162-6. doi: 10.12669/pjms.315.8132.

BACKGROUND & OBJECTIVES: Attention deficit hyperactivity disorder (ADHD) is a common heritable psychiatric disorder with a worldwide prevalence of 5%. The etiology of ADHD is still incompletely understood, but several studies, consistently indicate the strong role of genetic factors...

Cite
Kayyal M, Movafagh A, Hashemi M, et al. Association analysis of DISC1 gene polymorphisms with Attention-Deficit Hyperactivity Disorder in Iranian population. Pak J Med Sci. 2015;31(5):1162-6doi: 10.12669/pjms.315.8132.
Kayyal, M., Movafagh, A., Hashemi, M., Sayad, A., Emamalizadeh, B., PourIran, K., Kayyal, M., Amirabadi, M. R., Zamani, M., & Darvish, H. (2015). Association analysis of DISC1 gene polymorphisms with Attention-Deficit Hyperactivity Disorder in Iranian population. Pakistan journal of medical sciences, 31(5), 1162-6. https://doi.org/10.12669/pjms.315.8132
Kayyal, Matin, et al. "Association analysis of DISC1 gene polymorphisms with Attention-Deficit Hyperactivity Disorder in Iranian population." Pakistan journal of medical sciences vol. 31,5 (2015): 1162-6. doi: https://doi.org/10.12669/pjms.315.8132
Kayyal M, Movafagh A, Hashemi M, Sayad A, Emamalizadeh B, PourIran K, Kayyal M, Amirabadi MR, Zamani M, Darvish H. Association analysis of DISC1 gene polymorphisms with Attention-Deficit Hyperactivity Disorder in Iranian population. Pak J Med Sci. 2015 Sep-Oct;31(5):1162-6. doi: 10.12669/pjms.315.8132. PMID: 26649006; PMCID: PMC4641275.
Copy Download .nbib Format: NLM
Natural deep eutectic solvents: cytotoxic profile.

SpringerPlus

Hayyan M, Mbous YP, Looi CY, Wong WF, Hayyan A, Salleh Z, Mohd-Ali O.
PMID: 27386357
Springerplus. 2016 Jun 29;5(1):913. doi: 10.1186/s40064-016-2575-9. eCollection 2016.

The purpose of this study was to investigate the cytotoxic profiles of different ternary natural deep eutectic solvents (NADESs) containing water. For this purpose, five different NADESs were prepared using choline chloride as a salt, alongside five hydrogen bond...

Cite
Hayyan M, Mbous YP, Looi CY, et al. Natural deep eutectic solvents: cytotoxic profile. Springerplus. 2016;5(1):913doi: 10.1186/s40064-016-2575-9.
Hayyan, M., Mbous, Y. P., Looi, C. Y., Wong, W. F., Hayyan, A., Salleh, Z., & Mohd-Ali, O. (2016). Natural deep eutectic solvents: cytotoxic profile. SpringerPlus, 5(1), 913. https://doi.org/10.1186/s40064-016-2575-9
Hayyan, Maan, et al. "Natural deep eutectic solvents: cytotoxic profile." SpringerPlus vol. 5,1 (2016): 913. doi: https://doi.org/10.1186/s40064-016-2575-9
Hayyan M, Mbous YP, Looi CY, Wong WF, Hayyan A, Salleh Z, Mohd-Ali O. Natural deep eutectic solvents: cytotoxic profile. Springerplus. 2016 Jun 29;5(1):913. doi: 10.1186/s40064-016-2575-9. eCollection 2016. PMID: 27386357; PMCID: PMC4927554.
Copy Download .nbib Format: NLM
Abdominal Pain and Weight Loss in New-Onset Type 1 Diabetes.

Clinical diabetes : a publication of the American Diabetes Association

Aslam A, Byrne J, Rajbhandari SM.
PMID: 26246675
Clin Diabetes. 2014 Jan;32(1):26-7. doi: 10.2337/diaclin.32.1.26.

No abstract available.

Cite
Aslam A, Byrne J, Rajbhandari SM. Abdominal Pain and Weight Loss in New-Onset Type 1 Diabetes. Clin Diabetes. 2014;32(1):26-7doi: 10.2337/diaclin.32.1.26.
Aslam, A., Byrne, J., & Rajbhandari, S. M. (2014). Abdominal Pain and Weight Loss in New-Onset Type 1 Diabetes. Clinical diabetes : a publication of the American Diabetes Association, 32(1), 26-7. https://doi.org/10.2337/diaclin.32.1.26
Aslam, Amir, et al. "Abdominal Pain and Weight Loss in New-Onset Type 1 Diabetes." Clinical diabetes : a publication of the American Diabetes Association vol. 32,1 (2014): 26-7. doi: https://doi.org/10.2337/diaclin.32.1.26
Aslam A, Byrne J, Rajbhandari SM. Abdominal Pain and Weight Loss in New-Onset Type 1 Diabetes. Clin Diabetes. 2014 Jan;32(1):26-7. doi: 10.2337/diaclin.32.1.26. PMID: 26246675; PMCID: PMC4521428.
Copy Download .nbib Format: NLM
One-Year Multicenter Double-Blind Randomized Clinical Trial on the Efficacy and Safety of Generic Cyclosporine (Iminoral) in De Novo Kidney Transplant Recipients.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation

Khatami SM, Taheri S, Azmandian J, Sagheb MM, Nazemian F, Razeghi E, Shahidi S, Sadri F, Shamshiri AR, Sayyah M.
PMID: 24206081
Exp Clin Transplant. 2013 Nov 08; doi: 10.6002/ect.2013.0139. Epub 2013 Nov 08.

OBJECTIVES: Iminoral is the generic microemulsion of cyclosporine. We performed a randomized double-blind multicenter trial to evaluate its efficacy and safety compared with the innovator medication Neoral for preventing acute rejection episodes in adult patients during the first year...

Cite
Khatami SM, Taheri S, Azmandian J, et al. One-Year Multicenter Double-Blind Randomized Clinical Trial on the Efficacy and Safety of Generic Cyclosporine (Iminoral) in De Novo Kidney Transplant Recipients. Exp Clin Transplant. 2013;doi: 10.6002/ect.2013.0139.
Khatami, S. M., Taheri, S., Azmandian, J., Sagheb, M. M., Nazemian, F., Razeghi, E., Shahidi, S., Sadri, F., Shamshiri, A. R., & Sayyah, M. (2013). One-Year Multicenter Double-Blind Randomized Clinical Trial on the Efficacy and Safety of Generic Cyclosporine (Iminoral) in De Novo Kidney Transplant Recipients. Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, . https://doi.org/10.6002/ect.2013.0139
Khatami, Seyyed Mohammad Reza, et al. "One-Year Multicenter Double-Blind Randomized Clinical Trial on the Efficacy and Safety of Generic Cyclosporine (Iminoral) in De Novo Kidney Transplant Recipients." Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation vol. (2013). doi: https://doi.org/10.6002/ect.2013.0139
Khatami SM, Taheri S, Azmandian J, Sagheb MM, Nazemian F, Razeghi E, Shahidi S, Sadri F, Shamshiri AR, Sayyah M. One-Year Multicenter Double-Blind Randomized Clinical Trial on the Efficacy and Safety of Generic Cyclosporine (Iminoral) in De Novo Kidney Transplant Recipients. Exp Clin Transplant. 2013 Nov 08; doi: 10.6002/ect.2013.0139. Epub 2013 Nov 08. PMID: 24206081.
Copy Download .nbib Format: NLM
Predictive factors for time to remission and recurrence in patients treated for acute mania: health outcomes of manic episodes (HOME) study.

Primary care companion to the Journal of clinical psychiatry

Kora K, Saylan M, Akkaya C, Karamustafalioglu N, Tomruk N, Yasan A, Oral T.
PMID: 18458722
Prim Care Companion J Clin Psychiatry. 2008;10(2):114-9. doi: 10.4088/pcc.v10n0205.

OBJECTIVE: To determine the time to remission and recurrence in patients treated for acute mania and the predictive factors associated with these outcomes.METHOD: This observational study, conducted in Turkey from April 2003 to January 2005, included patients with a...

Cite
Kora K, Saylan M, Akkaya C, et al. Predictive factors for time to remission and recurrence in patients treated for acute mania: health outcomes of manic episodes (HOME) study. Prim Care Companion J Clin Psychiatry. 2008;10(2):114-9doi: 10.4088/pcc.v10n0205.
Kora, K., Saylan, M., Akkaya, C., Karamustafalioglu, N., Tomruk, N., Yasan, A., & Oral, T. (2008). Predictive factors for time to remission and recurrence in patients treated for acute mania: health outcomes of manic episodes (HOME) study. Primary care companion to the Journal of clinical psychiatry, 10(2), 114-9. https://doi.org/10.4088/pcc.v10n0205
Kora, Kaan, et al. "Predictive factors for time to remission and recurrence in patients treated for acute mania: health outcomes of manic episodes (HOME) study." Primary care companion to the Journal of clinical psychiatry vol. 10,2 (2008): 114-9. doi: https://doi.org/10.4088/pcc.v10n0205
Kora K, Saylan M, Akkaya C, Karamustafalioglu N, Tomruk N, Yasan A, Oral T. Predictive factors for time to remission and recurrence in patients treated for acute mania: health outcomes of manic episodes (HOME) study. Prim Care Companion J Clin Psychiatry. 2008;10(2):114-9. doi: 10.4088/pcc.v10n0205. PMID: 18458722; PMCID: PMC2292434.
Copy Download .nbib Format: NLM
Amphiphilic gold nanoparticles with V-shaped arms.

Journal of the American Chemical Society

Zubarev ER, Xu J, Sayyad A, Gibson JD.
PMID: 16608322
J Am Chem Soc. 2006 Apr 19;128(15):4958-9. doi: 10.1021/ja060782h.

Here we describe a very efficient method to produce well-defined amphiphilic gold nanoparticles (Au NPs) with an equal number of hydrophobic and hydrophilic arms which are distributed along the surface of a 2-nm gold core in an alternating fashion....

Cite
Zubarev ER, Xu J, Sayyad A, et al. Amphiphilic gold nanoparticles with V-shaped arms. J Am Chem Soc. 2006;128(15):4958-9doi: 10.1021/ja060782h.
Zubarev, E. R., Xu, J., Sayyad, A., & Gibson, J. D. (2006). Amphiphilic gold nanoparticles with V-shaped arms. Journal of the American Chemical Society, 128(15), 4958-9. https://doi.org/10.1021/ja060782h
Zubarev, Eugene R, et al. "Amphiphilic gold nanoparticles with V-shaped arms." Journal of the American Chemical Society vol. 128,15 (2006): 4958-9. doi: https://doi.org/10.1021/ja060782h
Zubarev ER, Xu J, Sayyad A, Gibson JD. Amphiphilic gold nanoparticles with V-shaped arms. J Am Chem Soc. 2006 Apr 19;128(15):4958-9. doi: 10.1021/ja060782h. PMID: 16608322.
Copy Download .nbib Format: NLM
Diffusion enhancement in a periodic potential under high-frequency space-dependent forcing.

Physical review. E, Statistical, nonlinear, and soft matter physics

Bandyopadhyay M, Dattagupta S, Sanyal M.
PMID: 16802919
Phys Rev E Stat Nonlin Soft Matter Phys. 2006 May;73(5):051108. doi: 10.1103/PhysRevE.73.051108. Epub 2006 May 19.

We study the long-time behavior of an underdamped Brownian particle moving through a viscous medium and in a systematic potential, when it is subjected to a space-dependent high-frequency periodic force. When the frequency is very large, much larger than...

Cite
Bandyopadhyay M, Dattagupta S, Sanyal M. Diffusion enhancement in a periodic potential under high-frequency space-dependent forcing. Phys Rev E Stat Nonlin Soft Matter Phys. 2006;73(5):051108doi: 10.1103/PhysRevE.73.051108.
Bandyopadhyay, M., Dattagupta, S., & Sanyal, M. (2006). Diffusion enhancement in a periodic potential under high-frequency space-dependent forcing. Physical review. E, Statistical, nonlinear, and soft matter physics, 73(5), 051108. https://doi.org/10.1103/PhysRevE.73.051108
Bandyopadhyay, Malay, et al. "Diffusion enhancement in a periodic potential under high-frequency space-dependent forcing." Physical review. E, Statistical, nonlinear, and soft matter physics vol. 73,5 (2006): 051108. doi: https://doi.org/10.1103/PhysRevE.73.051108
Bandyopadhyay M, Dattagupta S, Sanyal M. Diffusion enhancement in a periodic potential under high-frequency space-dependent forcing. Phys Rev E Stat Nonlin Soft Matter Phys. 2006 May;73(5):051108. doi: 10.1103/PhysRevE.73.051108. Epub 2006 May 19. PMID: 16802919.
Copy Download .nbib Format: NLM
Serotonin receptor modulators in the treatment of irritable bowel syndrome.

Therapeutics and clinical risk management

Fayyaz M, Lackner JM.
PMID: 18728719
Ther Clin Risk Manag. 2008 Feb;4(1):41-8. doi: 10.2147/tcrm.s140.

The aim of this article is to review the pathophysiology and clinical role of serotonin receptor modulators used in the treatment of irritable bowel syndrome. Serotonin is an important monoamine neurotransmitter that plays a key role in the initiation...

Cite
Fayyaz M, Lackner JM. Serotonin receptor modulators in the treatment of irritable bowel syndrome. Ther Clin Risk Manag. 2008;4(1):41-8doi: 10.2147/tcrm.s140.
Fayyaz, M., & Lackner, J. M. (2008). Serotonin receptor modulators in the treatment of irritable bowel syndrome. Therapeutics and clinical risk management, 4(1), 41-8. https://doi.org/10.2147/tcrm.s140
Fayyaz, Mohammad, and Lackner, Jeffrey M. "Serotonin receptor modulators in the treatment of irritable bowel syndrome." Therapeutics and clinical risk management vol. 4,1 (2008): 41-8. doi: https://doi.org/10.2147/tcrm.s140
Fayyaz M, Lackner JM. Serotonin receptor modulators in the treatment of irritable bowel syndrome. Ther Clin Risk Manag. 2008 Feb;4(1):41-8. doi: 10.2147/tcrm.s140. PMID: 18728719; PMCID: PMC2503665.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 365 entries